Clinical Trial

Effectiveness of Transcranial Direct Current Stimulation (tDCS) in the Management of Complex Regional Pain Syndrome

Study acronym: ALGOSTIM
Recruiting
View on ClinicalTrials.gov →
Summary
Transcranial direct current stimulation (tDCS) is a non-invasive therapy increasingly used in facilities treating patients with chronic pain. This complementary therapy has the advantage of being non-pharmacological, with transient and mild side effects, an excellent safety profile, and good efficacy in the contexts where it has been the subject of dedicated research: neuropathic pain, fibromyalgia, and visceral pain. Few studies have focused on the application of tDCS in the context of complex regional pain syndrome (CRPS), which is a common condition.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-19
Trial Details
NCT Number NCT07361692
Lead Sponsor Polyclinique de l'Europe
Conditions Complex Regional Pain Syndrome (CRPS)
Enrollment 32 participants
Start Date 2026-04-01
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-18